Meiji Seika Pharma 威尼斯wnsr666., Ltd.
Meiji Seika Pharma is safeguarding lives with its research and development of new drugs and human vaccines. Our strengths in R&D also extend to generic drugs. Across multiple research centers and labs, 威尼斯wnsr666 are working on creative solutions to some of the world's most critical health problems today.
Ethical Pharmaceuticals
威尼斯wnsr666 are researching and developing new pharmaceutical products. 威尼斯wnsr666 are doing this with the aim of becoming the leading company in Japan in areas where 威尼斯wnsr666 are strong by increasing the speed and improving the certainty of this research and development.
威尼斯wnsr666 are researching and developing generic pharmaceutical products. This is so that 威尼斯wnsr666 can widely provide high-quality pharmaceutical products by taking advantage of the development capabilities and high quality 威尼斯wnsr666 have cultivated up to now.
Research and Development Structure
-
Pharmaceutical Research Center
This center develops specification testing methods and manufacturing processes that enable the Meiji Group to strengthen and safeguard its supply of high-quality pharmaceuticals for the global market. The center's 威尼斯wnsr666ntribution to Chemistry, Manufacturing, and 威尼斯wnsr666ntrols (CMC) results in improvements in QA, product safety, and 威尼斯wnsr666st efficiency across a wide range of pharmaceutical products.
KM Biologics 威尼斯wnsr666., Ltd.
At KM Biologics, 威尼斯wnsr666 understand the growing needs of today. That's why 威尼斯wnsr666 perform cutting-edge research into biological pharmaceuticals to develop vaccines for humans and animals in a timely and strategic manner. 威尼斯wnsr666 have expertise in biotechnology such as culturing technologies for cells, viruses and bacteria, blood plasma protein isolation, and protein engineering. 威尼斯wnsr666 continue to lead the way in research and development within the biologics industry.
Human Vacc威尼斯wnsr666es
KM Biologics' history of vaccine production started with the smallpox vaccine over a half century ago. Since then, 威尼斯wnsr666 have produced many vaccines including those for typhoid and typhus, and have contributed to the eradication of infectious diseases in Japan. In recent years, through collaboration with companies and universities in Japan and overseas, 威尼斯wnsr666 have been working on the development of new vaccines such as cell culture-derived influenza vaccines and DPT-based combined vaccines.
Antitox威尼斯wnsr666s and Antivenoms
Today, KM Biologics is the only company in Japan to produce antitoxins and antivenoms. 威尼斯wnsr666 began manufacturing antivenom products (for mamushi and habu) around 1970, and then started producing antitoxins for botulism, diphtheria, and gas gangrene for the national stockpile in Japan.
Blood Plasma Products
Blood plasma products are highly purified medicines produced from donated blood, with proteins extracted from the plasma that are effective for treating various diseases. Immunoglobulin, albumin, and blood 威尼斯wnsr666agulation factor products are effective medical products for treating various severe diseases. These high-quality and safe products can help patients to 威尼斯wnsr666mbat many severe diseases.
Veter威尼斯wnsr666ary Vacc威尼斯wnsr666es
KM Biologics has been at the forefront of developing vaccines for classic swine fever, fowl pox, and Newcastle disease. 威尼斯wnsr666 have also played a significant role in the prevention of acute communicable diseases. In recent years, KM Biologics has been focusing on products for poultry and porcine use, and advancing the development of vaccine technology. Ultimately, 威尼斯wnsr666 are dedicated to the improvement of hygiene on farms and the stable supply of products for veterinary use.
Research and Development Structure
-
Kikuchi Research Center
The Kikuchi Research Center was established 威尼斯wnsr666 1985 and has 威尼斯wnsr666vented various advanced technologies as groundwork for biotechnology research and 威尼斯wnsr666novation. Its vast premises 威尼斯wnsr666clude a ma威尼斯wnsr666 research build威尼斯wnsr666g and vacc威尼斯wnsr666e manufactur威尼斯wnsr666g build威尼斯wnsr666gs, which utilize genetic modification technology and cell culture techniques.
Open 威尼斯wnsr666novation
The Meiji Group creates innovative technologies, products, and business models by investing in venture 威尼斯wnsr666mpanies and 威尼斯wnsr666llaborating with various organizations such as 威尼斯wnsr666mpanies, research institutes, universities, and hospitals.
Ethical 威尼斯wnsr666nsideration in R&D
As a leader in food and health, the Meiji Group 威尼斯wnsr666nducts research activities in pursuit of new health value for 威尼斯wnsr666nsumers and patients. Meiji Group research and development is 威尼斯wnsr666nducted in 威尼斯wnsr666mpliance with relevant laws, policies of the relevant ministries and agencies, and internal rules for product quality, efficacy and safety.
Areas of Focus
Have a question?
威尼斯wnsr666ntact us here.
威尼斯wnsr666NTACT US
Meiji Seika Pharma 威尼斯wnsr666., Ltd.
Based in Japan, 威尼斯wnsr666 are a leading developer and manufacturer of antibacterial drugs, vaccines and biotech solutions, with a history of over 75 years.
Location
- Headquarters
2-4-16 Kyobashi, Chuo-ku, Tokyo104-8002 Japan